3K5D
Crystal Structure of BACE-1 in complex with AHM178
3K5D の概要
エントリーDOI | 10.2210/pdb3k5d/pdb |
関連するBIRD辞書のPRD_ID | PRD_000675 |
分子名称 | Beta-secretase 1, N-acetyl-L-leucyl-N-[(4S,5S,7R)-8-(butylamino)-5-hydroxy-2,7-dimethyl-8-oxooctan-4-yl]-L-methioninamide (3 entities in total) |
機能のキーワード | aspartyl protease, alzheimer's disease, endoplasmic reticulum, endosome, glycoprotein, golgi apparatus, membrane, protease, transmembrane, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Membrane; Single-pass type I membrane protein: P56817 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 137939.24 |
構造登録者 | |
主引用文献 | Hanessian, S.,Shao, Z.,Betschart, C.,Rondeau, J.M.,Neumann, U.,Tintelnot-Blomley, M. Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors. Bioorg.Med.Chem.Lett., 20:1924-1927, 2010 Cited by PubMed Abstract: Starting from peptidomimetic BACE-1 inhibitors, the P2 amino acid including the P2/P3 peptide bond was replaced by a rigid 3-aminomethyl cyclohexane carboxylic acid. Co-crystallization revealed an unexpected binding mode with the P3/P4 amide bond placed into the S3 pocket resulting in a new hydrogen bond interaction pattern. Further optimization based on this structure resulted in highly potent BACE-1 inhibitors with selectivity over BACE-2 and cathepsin D. PubMed: 20172717DOI: 10.1016/j.bmcl.2010.01.139 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.9 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード